Jacqueline examines how glucagon-like peptide-1 (GLP-1)–based medications, like semaglutide and tirzepatide, influence reward-related eating and broader reward processes. This work considers whether medication-associated changes differ across dimensions of reward (e.g., food noise, enjoyment, cravings, etc.) and across types of foods (e.g., ultraprocessed foods vs minimally processed foods).
Jacqueline investigates individual differences associated with responses to various anti-obesity medications. A particular focus is how patterns of reward-related eating may explain variability in weight change and medication adherence among people using anti-obesity medications.
This work includes examining food-level and person-level characteristics that contribute to reward-related eating and how these factors interact. Specifically, Jacqueline is interested in properties of foods that make them highly salient or rewarding and individual differences (e.g., BMI, biological sex) that may shape how people experience and respond to food.